Improve the results of phase II trials of thromboprophylaxis with the new oral anticoagulant drugs

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH10-09-0584
Issue:2010: 104/6 (Dec) pp. 1083-1289
Pages:1083-1084

Improve the results of phase II trials of thromboprophylaxis with the new oral anticoagulant drugs

Editorial on Weitz et al.

P. J. Zufferey (1, 2), C. M. Samama (3), N. Rosencher (4)

(1) Thrombosis Research Group (EA 3065), University Jean Monnet, Saint-Etienne, France; (2) Department of Anaesthesiology and Intensive Care, University Hospital, Saint-Etienne, France; (3) AP-HP, Department of Anaesthesiology and Intensive Care, Hôtel Dieu Hospital, Paris Descartes University Paris, France; (4) AP-HP, Cochin Department of Anaesthesiology and Intensive Care, Paris-Descartes University, Paris, France

DOI

http://dx.doi.org/10.1160/TH10-09-0584

Articles

You've 7 Article(s) in your Basket.

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...